Table 1.
OLT n = 28 |
Control n = 7 |
p value | |
---|---|---|---|
Preoperative | |||
Female - n (%) | 10 (35.7 %) | 5 (71.4 %) | ns |
Age – mean ± SD [years] | 52.9 +/− 12.5 | 52.0 +/− 8.0 | ns |
MELD – mean ± SD | 17.8 +/− 9.0 | 8.7 +/− 3.3 | < 0.05 |
BMI– mean ± SD | 27.1 +/− 5.8 | 25.9 +/− 4.9 | ns |
Creatinine – mean ± SD [mg/dL] | 1.19 +/− 1.19 | 0.87 +/− 0.45 | ns |
Total Bilirubin – mean ± SD [mg/dL] | 6.6 +/− 9.3 | 0.9 +/− 0.8 | < 0.005 |
INR | 3.9 +/− 11.9 | 1.04 +/− 0.14 | ns |
Albumin | 3.94 +/− 5.15 | 4.14 +/− 0.49 | ns |
Ascites - n (%) | 13 (46.4 %) | 0 | ns |
LRLT - n (%) | 6 (21.4 %) | - | ns |
Indication for Surgery | |||
Hepatitis C -n (%) | 16 (57.1 %) | 0 | |
ETOH -n (%) | 3 (10.7 %) | 0 | |
PSC –n (%) | 4 (14.3 %) | 0 | |
HCC -n (%) | 9 (32.1 %) | 1 (14.3 %) | |
Others -n (%) | 5 (17.9 %) | 2 (28.6 %) | |
Pancreatic Ca -n (%) | - | 3 (42.9 %) | |
Living liver donor -n (%) | - | 1 (14.3 %) | |
Intraoperative | |||
Length of anesthesia – mean ± SD [hours] | 11.2 +/− 2.5 | 9.2 +/− 3.4 | ns |
Re-operation - n (%) | 2 (7.1 %) | 0 | ns |
PRBC – mean ± SD [Units] | 14.1 +/− 4.8 | 4.4 +/− 5.6 | ns |
FFP – mean ± SD [Units] | 15.4 +/− 14.7 | 2.9 +/− 4.2 | < 0.05 |
MELD- Model for End-stage Liver Disease score
BMI - Body mass index
INR - International normalized ratio
LRLT – Living related liver transplant
ETOH – alcohol induced hepatic cirrhosis
PSC – Primary sclerosing cholangitis
HCC - Hepato-cellular carcinoma
PRBC - number of packed red blood cells used intraoperatively
FFP – number of fresh frozen plasma used intraoperatively